Skip to Content

LCE 125 (Stalevo 125 31.25 mg / 200 mg / 125 mg)

Generic Name: carbidopa/entacapone/levodopa

Pill with imprint LCE 125 is Red, Elliptical / Oval and has been identified as Stalevo 125 31.25 mg / 200 mg / 125 mg. It is supplied by Novartis Pharmaceuticals.

Stalevo 125 is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Stalevo 125 31.25 mg / 200 mg / 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LCE 125

Stalevo 125

Generic Name:
carbidopa/entacapone/levodopa
Imprint:
LCE 125
Strength:
31.25 mg / 200 mg / 125 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals
Inactive Ingredients:
corn starch
croscarmellose sodium
glycerin
hypromelloses
magnesium stearate
mannitol
polysorbate 80
povidone
sucrose
ferric oxide red
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00781-5641 Sandoz Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide